Your browser doesn't support javascript.
loading
Icaritin-induced immunomodulatory efficacy in advanced hepatitis B virus-related hepatocellular carcinoma: Immunodynamic biomarkers and overall survival.
Qin, Shu-Kui; Li, Qing; Ming Xu, Jian; Liang, Jun; Cheng, Ying; Fan, Ying; Jiang, Jun; Ye, Hao; Tao, Huimin; Li, Lian; Zheng, Limin; Wei, Zhaohui; Li, Shu; Meng, Kun; Ye, Bin; Sun, Yan.
Afiliação
  • Qin SK; Clinical Oncology Department, Nanjing Jinling Hospital, Nanjing, China.
  • Li Q; National Cancer Center/National Clinical Research Center, Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Ming Xu J; The 5th Medical Centre, Chinese PLA General Hospital, Beijing, China.
  • Liang J; Clinical Oncology Department, The Affiliated Hospital of Qingdao University, Qingdao, China.
  • Cheng Y; Clinical Oncology Department, Jilin Cancer Hospital, Changchun, China.
  • Fan Y; National Cancer Center/National Clinical Research Center, Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Jiang J; National Cancer Center/National Clinical Research Center, Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
  • Ye H; Research & Development Department, SinoTech Genomics, Shanghai, China.
  • Tao H; School of Life Science, Sun Yat-Sen University, Guangzhou, China.
  • Li L; School of Life Science, Sun Yat-Sen University, Guangzhou, China.
  • Zheng L; School of Life Science, Sun Yat-Sen University, Guangzhou, China.
  • Wei Z; Biostatistical Department, Tigermed Consulting Co., Ltd., Shanghai, China.
  • Li S; Research & Clinical Development, Shenogen Pharma Group, Beijing, China.
  • Meng K; Research & Clinical Development, Shenogen Pharma Group, Beijing, China.
  • Ye B; Research & Clinical Development, Shenogen Pharma Group, Beijing, China.
  • Sun Y; National Cancer Center/National Clinical Research Center, Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China.
Cancer Sci ; 111(11): 4218-4231, 2020 Nov.
Article em En | MEDLINE | ID: mdl-32889778

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Flavonoides / Carcinoma Hepatocelular / Imunomodulação / Hepatite B / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Flavonoides / Carcinoma Hepatocelular / Imunomodulação / Hepatite B / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article